BamSEC and AlphaSense Join Forces
Learn More

Agenus Inc.

NASDAQ: AGEN    
Share price (8/8/25): $4.80    
Market cap (8/8/25): $132 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 86 pages Purchase and Sale Agreement Dated as of May 6, 2024 by and Among Agenus Inc., Agenus Royalty Fund, LLC, Agenus Holdings 2024, LLC and Ligand Pharmaceuticals Incorporated
12/34/56
EX-10.9A
from 10-K 3 pages Amendment No. 4 to Consulting Agreement
12/34/56
EX-10.2
from 10-Q 12 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 20 pages Executive Employment Agreement
12/34/56
EX-10.12.1
from 10-K 2 pages Amendment No. 3 to Consulting Agreement
12/34/56
EX-10.12
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.11.1
from 10-K 2 pages Amendment No. 2 to Consulting Agreement
12/34/56
EX-10.10.2
from 10-K 2 pages First Amendment to the Agenus Inc. 2019 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 3 pages Amendment No. 1 to Royalty Purchase Agreement
12/34/56
EX-10.1
from 10-Q 80 pages License, Development and Commercialization Agreement Dated as of May 17, 2021 by and Between Agenus Inc. and Bristol-Myers Squibb Company [**] = Portions of This Exhibit Have Been Omitted Pursuant to a Confidential Treatment Request. an Unredacted Version of This Exhibit Has Been Filed Separately With the Commission
12/34/56
EX-10.1
from 8-K 61 pages Office Lease Bay Center Offices Emeryville, California Bay Center Investor LLC, as Landlord, and Agenus Inc., as Tenant
12/34/56
EX-10.1
from 10-Q 19 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 54 pages License and Collaboration Agreement Article 1. Definitions
12/34/56
EX-10.1
from 10-Q 9 pages Consulting Agreement
12/34/56
EX-10.10.3
from 10-K 4 pages Agenus Inc. 2019 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.10.2
from 10-K 3 pages Agenus Inc. 2019 Equity Incentive Plan Non-Qualified Stock Option Stock Option Award Agreement
12/34/56
EX-10.10.1
from 10-K 4 pages Agenus Inc. 2019 Equity Incentive Plan Incentive Stock Option Stock Option Award Agreement
12/34/56
EX-10.2
from 10-Q 18 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Agenus Inc. 2019 Equity Incentive Plan
12/34/56
EX-10.27
from 10-K 66 pages Option and License Agreement (Agen2373) by and Between Agenus Inc. and Gilead Sciences, Inc. Dated as of December 20, 2018
12/34/56